Key result
p66Shc drives alpha1-adrenergic cardiomyocyte hypertrophy via ROS-dependent AKT-FOXO3a signaling and MnSOD downregulation.
Answers are grounded in this paper and cite their sources.
p66Shc is an adapter protein that is induced by hypertrophic stimuli and has been implicated as a major regulator of reactive oxygen species (ROS) production and cardiovascular oxidative stress responses. This study implicates p66Shc in an alpha(1)-adrenergtic receptor (alpha(1)-AR) pathway that requires the cooperative effects of protein kinase (PK)Cepsilon and PKCdelta and leads to AKT-FOXO3a phosphorylation in cardiomyocytes. alpha(1)-ARs promote p66Shc-YY(239/240) phosphorylation via a ROS-dependent mechanism that is localized to caveolae and requires epidermal growth factor receptor (EGFR) and PKCepsilon activity. alpha(1)-ARs also increase p66Shc-S(36) phosphorylation via an EGFR transactivation pathway involving PKCdelta. p66Shc links alpha(1)-ARs to an AKT signaling pathway that selectively phosphorylates/inactivates FOXO transcription factors and downregulates the ROS-scavenging protein manganese superoxide dismutase (MnSOD); the alpha(1)-AR-p66Shc-dependent pathway involving AKT does not regulate GSK3. Additional studies show that RNA interference-mediated downregulation of endogenous p66Shc leads to the derepression of FOXO3a-regulated genes such as MnSOD, p27Kip1, and BIM-1. p66Shc downregulation also increases proliferating cell nuclear antigen expression and induces cardiomyocyte hypertrophy, suggesting that p66Shc exerts an antihypertrophic action in neonatal cardiomyocytes. The novel alpha(1)-AR- and ROS-dependent pathway involving p66Shc identified in this study is likely to contribute to cardiomyocyte remodeling and the evolution of heart failure.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2009) studied Cardiomyocyte hypertrophy and remodeling. alpha(1)-adrenergic receptor stimulation and RNAi-mediated p66Shc downregulation was evaluated on AKT-FOXO3a phosphorylation, MnSOD downregulation, and cardiomyocyte hypertrophy. p66Shc links alpha(1)-adrenergic receptors to a ROS-dependent AKT-FOXO3a phosphorylation pathway that downregulates MnSOD and modulates cardiomyocyte hypertrophy.
Synapse has enriched 10 related papers. Consider them for comparative context: